Latest News in the pharma Industry

Research & Development

New treatments to solve global antibiotic crisis could reach the market by 2020

New treatments to solve global antibiotic crisis could reach the market by 2020

19 Nov 2017

New ARB technology rejuvenates existing antibiotics to outsmart antibiotic resistance.

Read more 
Bavencio becomes first treatment for rare skin cancer mMCC licensed for use in the UK

Bavencio becomes first treatment for rare skin cancer mMCC licensed for use in the UK

7 Nov 2017

The launch of avelumab marks a step-change in the way that mMCC can be treated.

Read more 
Novartis seeks leadership with Cosentyx

Novartis seeks leadership with Cosentyx

6 Nov 2017

For the first time for any biologic, data show almost 80% of ankylosing spondylitis patients on Cosentyx have no radiographic progression of the spine at 4 years.

Read more 
NousCom raises €42 million to develop off-the-shelf cancer vaccine

NousCom raises €42 million to develop off-the-shelf cancer vaccine

6 Nov 2017

Financing to advance its pipeline of neoantigen cancer-based immunotherapies to the clinic.

Read more 
RA patients treated with baricitinib reported greater improvements in pain compared with adalimumab

RA patients treated with baricitinib reported greater improvements in pain compared with adalimumab

5 Nov 2017

Post-hoc analysis shows pain improvement was consistent regardless of a patient's baseline pain severity.

Read more 
RedHill Biopharma and IntelGenx submit NDA to FDA for Rizaport for migraines

RedHill Biopharma and IntelGenx submit NDA to FDA for Rizaport for migraines

2 Nov 2017

Rizaport is a proprietary oral thin-film formulation of rizatriptan for the treatment of acute migraines.

Read more 
Cristal Therapeutics progresses nanomedicine CriPec-docetaxel to Phase Ib development

Cristal Therapeutics progresses nanomedicine CriPec-docetaxel to Phase Ib development

1 Nov 2017

This nanomedicine candidate is specifically designed to enable enhanced tumour accumulation and local drug release at the target site, to boost the therapeutic efficacy and to overcome the shortfalls associated with current docetaxel products.

Read more 
FDA approves AstraZeneca's Calquence for adult patients with mantle cell lymphoma

FDA approves AstraZeneca's Calquence for adult patients with mantle cell lymphoma

31 Oct 2017

Accelerated approval of Bruton tyrosine kinase inhibitor in MCL marks AstraZeneca's entry into the treatment of blood cancers.

Read more 
NIH study identifies new targets for anti-malaria drugs

NIH study identifies new targets for anti-malaria drugs

27 Oct 2017

The deadliest malaria parasite needs two proteins to infect red blood cells.

Read more 
First social-health research on the use of seawater in respiratory diseases

First social-health research on the use of seawater in respiratory diseases

25 Oct 2017

7 out of 10 users preferred seawater to traditional serum, claiming it even reduces sick days.

Read more 
Arch Biopartners initiates manufacturing process for Metablok

Arch Biopartners initiates manufacturing process for Metablok

17 Oct 2017

In pre-clinical studies, Metablok has shown it has the ability to prevent acute kidney injury by blocking the inflammatory response triggered by kidney ischemia/reperfusion.

Read more 
SGS and Bavarian Nordic to develop a novel and differentiated challenge model for RSV

SGS and Bavarian Nordic to develop a novel and differentiated challenge model for RSV

13 Oct 2017

Project will build upon the results of Phase II trials undertaken by Bavarian Nordic.

Read more